Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity

Table 3

Data of each premature infant treated by intravitreal injections of bevacizumab.

Case	Gender	GA (w)	BW (g)	ROP; (OD/OS)	PNA (w)	PMA (w)	Outcome; (OD/OS)
1	M	28	900	AP/AP	8	36	Good/bad
2	F	28	1000	AP/AP	5	33	Good/good
3	F	32	1800	AP/AP	4	36	Good/good
4	M	34	2300	3 I/3 I	4	38	Good/good
5	F	27	995	AP/AP	7	34	Good/good
6	F	30	1400	3 I/3 I	4	34	Good/good
7	M	30	1500	3 I/3 I	4	34	Good/good
8	F	26	1100	AP/AP	5	31	Good/good
9	F	28	990	AP/AP	6	34	Good/good
10	M	30	1650	3 I/3 I	7	37	Good/good
11	F	28	2050	3 I/3 I	6	34	Good/good
12	F	27	1100	AP/AP	8	35	Good/good
13	F	29	1140	AP/AP	8	37	Good/bad
14	M	30	1200	3 I/3 I	7	37	Good/good
15	F	27	970	AP/AP	6	33	Good/good
16	F	29	1070	AP/AP	6	35	Good/good
17	F	28	990	AP/AP	7	35	Good/good
18	M	28	1000	AP/AP	6	34	Good/good
19	F	31	1200	3 I/3 I	5	36	Good/good
20	F	31	1100	3 I/3 I	5	36	Good/good
21	F	30	1030	AP/AP	6	36	Good/good
22	M	28	990	AP/AP	7	35	Good/good
23	M	28	1100	AP/AP	7	35	Good/good
24	M	28	985	AP/AP	7	35	Good/good
25	M	31	1400	AP/AP	4	35	Bad/bad
26	M	32	1500	3 I/3 I	5	37	Good/good
27	M	31	1240	AP/AP	5	36	Good/good
28	F	31	1499	AP/AP	7	38	Bad/bad
29	M	27	1010	AP/AP	7	34	Good/good
30	F	26	1100	AP/AP	8	34	Bad/bad
31	F	27	950	AP/AP	7	34	Bad/bad
32	M	27	980	AP/AP	5	32	Good/good
33	M	28	1550	3 I/3 I	8	36	Good/good
34	F	27	800	AP/AP	10	37	Good/good
35	M	28	1390	AP/AP	7	35	Good/bad
36	F	31	1550	3 I/3 I	6	37	Good/good
37	M	28	1050	AP/AP	6	34	Good/good

AP = aggressive posterior; 3 I = stage 3 zone I.